ehealth Congress, Frankfurt am Main October 4, 2016

Transkript

1 ehealth Congress, Frankfurt am Main October 4, 2016

2 S. 2 aescuvest 2 REGULATED MARKETS HIT EACH OTHER: FINTECH MEETS HEALTHCARE!

3 S. 3 aescuvest INNOVATIONS OR NEGATIVE INTERESTS? High population growth until 2050 in particular in Africa and Asia (2050: 9.3 billion people) Ageing of the world population until 2050 more people in the age >60 years than <14 years In Zunahme Germany expected Erkrankungen increase bis of diseases 2050 in Deutschland until 2050 Cancer Krebs +50 %, %, Schlaganfall Stroke %, %, Heart Herzinfarkt attack +100 %, %, Dementia Demenz +100 %

4 AESCUVEST BUSINESS AREAS! Projects presented on aescuvest may belong to the following sectors but we ask to get inspired by ideas from different directions as well!

5 BECOME A SHAREHOLDER OF INNOVATIVE COMPANIES WITHIN 5 CLICKS! Platform Payment Provider Investor Inventor Loan

6 CROWDINVESTING IS REGULATED BY LEGISTLATION! No investment prospectus required up to 2.5M EUR Investment limit per person: From EUR up a self-information of every investor is mandatory to assess the accordance with individual affordability. It has to be confirmed that free capital reserves of EUR are disposable respectively a declaration is applicable to not invest more than the double amount of the individual monthly net income EUR is the upper limit for private investors. To invest higher amounts is only permitted for capital companies. Both corporate and private inestments are possible on aescuvest

7 THAT S HOW HEXAGONAUTS LOOK LIKE! Dr. rer. nat. Patrick Pfeffer Hexagonaut for strategic management Dipl.-Ing. Dieter Kern Hexagonaut for commercial management Jörg Diehl, MBA Hexagonaut for financial communication André Schulze, Betriebswirt & B. A. with Honours Hexagonaut for online marketing Christoph Maria Severin Hexagonaut for communication & press relations

8 SCIENTIFIC ADVISORY BOARD! Prof. Dr. jur. Thomas Schlegel Scientific advisory board medical law Prof. Dr. med. Clemens Bulitta Scientific advisory board medical technology Dr. med. Tobias D. Gantner, MBA, LL. M. Scientific advisory board digital health INVESTORS ADVISORY BOARD! Lukasz Sulkowski, Business graduate IT Investors advisory board Uwe Siebert, Diploma in Mathematics Investors advisory board

9 S. 9 aescuvest SHAREHOLDER = AMBASSADOR = CUSTOMER FROM EMPOWERED PATIENT TO EMPOWERED INVESTOR! Financing, Marketing and Distribution out of one hand On average 50k 75k people get faced with our fundings Smart money approach: targeting of pot. Customers The aescuvest network holds contacts to connected healthcare professionals EU-wide B2C / B2B / B2P

10 S. 10 aescuvest A NEW ASSET CLASS FOR INVESTORS! Invest in SMEs for everyone within a few clicks Transparent communication between investors and inventors Revenue resp. profit sharing options Investor-friendly exit scenarios Investments possible starting at 250 EUR

11 S. 11 aescuvest HEXAGONAUTS - INSIGHTS! AESCUVEST CUSTOMER DEMOGRAPHICS! Investors average age: % with a doctorate 21 % women 31 % medical practioners, 28 % finance professionals, 19 % engineers, 15 % retirees, 7 % others Women s average investments are on average EUR higher than male investments Women with a doctor degree invest on average EUR more than their male colleagues

12 FINANCED PROJECTS!

13 1 M EUR COLLECTED CAPITAL HAS BEEN EXCEEDED WITHIN OUR FIRST 12 OPERATING MONTHS!

14 AESCUVEST ROADMAP 2017 Increase national brand awareness (focus on strat. partnerships and affiliates) Roll out Nordics, Benelux, UK 2017 Make the public live and love à Health is a profit. For all of us.

15 S. 15 aescuvest THANK YOU FOR TRANSFORMING HEALTHCARE WITH US! Dr. rer. nat. Patrick Pfeffer aescuvest.de facebook.com/aescuvest twitter.com/aescuvest